Sumgen Biotech
Sumgen Biotech, a leading player in the biotechnology sector, is headquartered in China (CN) and operates extensively across Asia and beyond. Founded in 2015, the company has rapidly established itself as a pioneer in the development of innovative biopharmaceuticals and advanced therapeutics. Specialising in monoclonal antibodies and gene therapies, Sumgen Biotech distinguishes itself through its commitment to cutting-edge research and development. The company’s unique approach to bioprocessing and its robust pipeline of products have garnered significant attention in the industry. With a strong market position, Sumgen Biotech has achieved notable milestones, including successful collaborations with global pharmaceutical firms and recognition for its contributions to healthcare advancements. As it continues to expand its influence, Sumgen Biotech remains dedicated to improving patient outcomes through its transformative solutions.
DitchCarbon Score
How does Sumgen Biotech's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Sumgen Biotech's score of 0 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Sumgen Biotech's reported carbon emissions
Sumgen Biotech, headquartered in CN, currently does not have available carbon emissions data for the most recent year, nor do they have specified reduction targets or climate pledges. Without specific emissions figures or commitments, it is unclear how the company is addressing its carbon footprint or contributing to climate action within the biotechnology sector. As the industry increasingly focuses on sustainability, it is essential for companies like Sumgen Biotech to establish clear climate commitments and reduction strategies to align with global efforts to mitigate climate change.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Sumgen Biotech is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
